NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of CERo Therapeutics Holdings, Inc. CERo Therapeutics Holdings, Inc.’s securities were suspended on October 31, 2025 and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the ordinary shares, units, and rights of Bowen Acquisition Corp. Bowen Acquisition Corp’s securities were suspended on November 3, 2025 and have not trad
This is the newest page. Registered accounts read further back.